Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1A | P07327 | 3/20 | 0.32 |
| ▸ | ADH1C | P00326 | 2/20 | 0.32 |
| ▸ | ADH1B | P00325 | 1/20 | 0.32 |
| ▸ | ADH4 | P08319 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20542564 | 1.00 | ADH1A (0.32) | ADH1AADH1CADH1BADH4ALDH1A1 | |
| SCHEMBL3392347 | 1.00 | ADH1A (0.32) | ADH1AADH1CADH1BADH4ALDH1A1 | |
| SCHEMBL17656185 | 1.00 | ADH1A (0.32) | ADH1AADH1CADH1BADH4ALDH1A1 | |
| SCHEMBL17656188 | 1.00 | ADH1A (0.32) | ADH1AADH1CADH1BADH4ALDH1A1 | |
| SCHEMBL17656204 | 1.00 | ADH1A (0.32) | ADH1AADH1CADH1BADH4ALDH1A1 | |
| SCHEMBL17656201 | 1.00 | ADH1A (0.32) | ADH1AADH1CADH1BADH4ALDH1A1 | |
| SCHEMBL17656187 | 1.00 | ADH1A (0.32) | ADH1AADH1CADH1BADH4ALDH1A1 | |
| SCHEMBL3392343 | 1.00 | ADH1A (0.32) | ADH1AADH1CADH1BADH4ALDH1A1 | |
| SCHEMBL1230434 | 0.85 | ALDH1A1 (0.39) | ALDH1A1ALOX15 | |
| SCHEMBL1230432 | 0.85 | ALDH1A1 (0.39) | ALDH1A1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2391597-B1 | METHOD FOR PRODUCING PURE CYCLODODECANONE | BASF SE (DE) | 2018-08-22 | — | — | EP | disclosed |
| US-8188320-B2 | Process for preparing pure cyclododecanone | BASF SE (DE) | 2012-05-29 | — | — | US | disclosed |
| US-20100191018-A1 | PROCESS FOR PREPARING PURE CYCLODODECANONE | BASF SE (DE) | 2010-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100191018-A1 | PROCESS FOR PREPARING PURE CYCLODODECANONE | CCNA1, CYC1, CCNA2 | ADH1A 113/4885ADH1C 30/4885ADH1B 511/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.